Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Disease Awareness Ad Guidance Stresses Need For “Distinct” Messages

Executive Summary

The impact of FDA's draft guidance on disease awareness ads will depend upon how willing manufacturers are to allot portions of their advertising budgets to non-branded ads

You may also be interested in...



Disease Awareness Ads Increase, Along With Firms’ Need For Clarity From FDA

Industry would like greater clarification from FDA on appropriate disease awareness advertising when the agency finalizes its draft guidance

Disease Awareness Ads Increase, Along With Firms’ Need For Clarity From FDA

Industry would like greater clarification from FDA on appropriate disease awareness advertising when the agency finalizes its draft guidance

Merck RotaTeq Approval Will Bring Spring Shower Of Disease Awareness Ads

Merck will begin a targeted disease awareness print and internet advertising campaign this spring as part of the launch of the rotavirus vaccine RotaTeq

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS043292

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel